Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BORTEZOMIB[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[17] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬
2Bortezomib (Velcade®)[1] Bortezomib[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 66 💬
3Bortezomib Accord[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
4Bortezomib D-mannitol[3] Bortezomib,
Bortezomib D-mannitol,
Mannitol		[2] Mannitol ,
Bortezomib 💬		[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
5Bortezomib Injection[1] Bortezomib[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 64 💬
6Bortezomib/dexamethasone[2] Bortezomib,
Dexamethasone		[2] Dexamethasone ,
Bortezomib 💬		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283 💬
7Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone[2] Bortezomib,
Dexamethasone		[2] Dexamethasone ,
Bortezomib 💬		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
8Combination of a single dose anti-CD20 antibody and bortezomib[1] Bortezomib[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 61 💬
9Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
10Cyclophosphamide, Bortezomib, dexamethasone[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
11Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab[4] Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		[5] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide ,
Daratumumab 💬		[3] CD38,
NR3C1,
PSMB5 💬		[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬
12SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬